Treatment outcomes and survival analysis of pediatric mature B-Cell non-Hodgkin lymphoma: A retrospective study comparing LMB96 and R-CHOP regimens
Advanced-stage B-NHL remains prevalent, with significant survival differences based on staging and risk classification. The transition from LMB96 to R-CHOP warrants further evaluation to optimize pediatric treatment strategies. Larger studies are needed to validate observed gender-based survival trends.
Authors
- Shaima Jabbar (ORCID: https://orcid.org/0009-0008-2579-3613)
- Mohammed Fawzi Alqanbar (ORCID: https://orcid.org/0009-0002-1723-0112)
- Usama Al‐Jumaily (ORCID: https://orcid.org/0000-0002-3507-7732)
- Safa A. Faraj (ORCID: https://orcid.org/0000-0002-4126-055X)
- Dheyaa Aldeen Al-Khateeb
- Inas Muayad Mohammed Ali (ORCID: https://orcid.org/0000-0001-6733-9736)
- Hamid D Habeeb Rjeib
Institutions
- University of Wasit (IQ)
- University of Al-Qadisiyah (IQ)
- University of Kerbala (IQ)
Publication Details
- Journal
- Leukemia Research Reports
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.lrr.2025.100531
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00